Big Opportunities of Brain Tumor Therapeutics: Global Markets to 2023
Press Release – 16 Jan 2019 Research and Development News -- . . Latest Update "Brain Tumor Therapeutics: Global Markets to 2023" with Industries Survey | Global Current Growth and Future. ' ' The global brain tumor therapeutics market was valued at REDACTED in 2017 and is expected to witness a compound annual growth rate (CAGR) of REDACTED, to reach a value of REDACTED in 2023. The mortality rate of brain cancer in both adult and pediatric population is very high. According to the Global Cancer Observatory, around 241,037 patients are expected to die globally due to brain tumors in 2018. The high recurrence rate of malignant brain tumors is due to reappearance of focal masses, indicating that a sub population of tumor cells in these cancers may be insensitive to current therapies and may be responsible for reinitiating tumor growth. This necessitates the development of newer drugs in the market that demonstrate greater efficacy in treating such aggress